Mass Eye and Ear-led phase 1/2 trial, which included 14 participants, found that the first-of-its-kind experimental treatment was safe and efficacious. BRILLIANCE trial results showed...
from SciTechDaily https://ift.tt/eHJu6bM
Gene Editing Breakthrough: CRISPR Improves Vision in Clinical Trial
May 13, 2024
0
Tags
